α-Gal Nanoparticles in CNS Trauma: II. Immunomodulation Following Spinal Cord Injury (SCI) Improves Functional Outcomes

Bhavani Gopalakrishnan,Uri Galili,Megan Saenger,Noah J. Burket,Wendy Koss,Manjari S. Lokender,Kaitlyn M. Wolfe,Samantha J. Husak,Collin J. Stark,Luis Solorio,Abigail Cox,August Dunbar,Riyi Shi,Jianming Li
DOI: https://doi.org/10.1007/s13770-023-00616-y
2024-02-05
Tissue Engineering and Regenerative Medicine
Abstract:Previous investigations have shown that local application of nanoparticles presenting the carbohydrate moiety galactose-α-1,3-galactose (α-gal epitopes) enhance wound healing by activating the complement system and recruiting pro-healing macrophages to the injury site. Our companion in vitro paper suggest α-gal epitopes can similarly recruit and polarize human microglia toward a pro-healing phenotype. In this continuation study, we investigate the in vivo implications of α-gal nanoparticle administration directly to the injured spinal cord.
engineering, biomedical,cell & tissue engineering
What problem does this paper attempt to address?